MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Vowel characteristics associated with Parkinson’s disease in Cantonese

    N. Leung, E. Tong, M. Ng (Pokfulam, Hong Kong)

    Objective: Dopaminergic treatment has been reported to help motor problem associated with Parkinson's disease (PD), but not speech motor. The current study examined vowel articulation…
  • 2018 International Congress

    The validity of the Arabic King’s PD Pain Scale in people with Parkinson’s disease

    H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorofat (Irbid, Jordan)

    Objective: This study aimed to examine the concurrent validity of Arabic translated version of the King's PD Pain Scale (KPPS) in people with Parkinson’s disease…
  • 2018 International Congress

    Relationship of Vitamin D deficiency with Parkinson’s disease risk

    M. Sanoeva, N. Mansurova (Bukhara, Uzbekistan)

    Objective: To study the level of vitamin D in the serum of Parkinson’s disease patients in the involvement of disease risk. Background: The Parkinson’s disease…
  • 2018 International Congress

    Predictors of freezing of gait in newly diagnosed Parkinson’s disease: Clinical, dopamine transporter imaging and CSF markers in the PPMI cohort

    R. Kim, J. Lee, H.J. Kim, A. Kim, B. Jeon, U.J. Kang, S. Fahn (Seoul, Republic of Korea)

    Objective: To examine whether clinical, dopamine transporter (DAT) imaging and cerebrospinal fluid (CSF) markers can be used to predict the later development of FOG individually…
  • 2018 International Congress

    Decreased amyloid-beta in patients with Idiopathic Parkinson’s Disease and white matter hyperintensities

    I. Markaki, S. Klironomos, P. Svenningsson (Stockholm, Sweden)

    Objective: The aim of this study is to investigate the clinical and biochemical profile of patients with PD with and without WMH. Background: Parkinson’s disease…
  • 2018 International Congress

    Microbiota DNA in the blood of patients with Parkinson’s disease

    S.Q. Xu, Y.W. Qian, X.D. Yang, S.D. Chen, Q. Xiao (Shanghai, China)

    Objective: The aim of this study was to explore the blood microbiota compositions in Chinese patients with Parkinson’s disease (PD). Background: Emerging evidences suggest that…
  • 2018 International Congress

    Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Cerebrospinal Fluid C-Reactive Protein

    H. Sanjari Moghaddam, M.H. Aarabi (Tehran, Islamic Republic of Iran)

    Objective: In this study, we intended to investigate the association between severity of PD motor symptoms and the cerebrospinal fluid (CSF) levels of CRP using…
  • 2018 International Congress

    The Prevalence of Tandem Gait Abnormality in Parkinson’s Disease

    J. Margolesky, S. Bette, D. Shpiner, T. Rundek, C. Luca, H. Moore, C. Singer (Miami, FL, USA)

    Objective: To assess the prevalence of tandem gait abnormality in patients with Parkinson’s disease (PD), comparing Hoehn and Yahr (HY) stages 2 and 3. Background:…
  • 2018 International Congress

    Pimavanserin Combined With Anti-Dementia Medications for Parkinson Disease Psychosis

    A. Espay, M. Guskey, N. Larsen, B. Coate, J. Vizcarra, S. Factor, J. Friedman, D. Weintraub, A. Lang (Cincinnati, OH, USA)

    Objective: To evaluate the differential antipsychotic effect of pimavanserin, a selective serotonin (5-HT2A) receptor inverse agonist, for Parkinson’s disease psychosis with and without concomitant anti-dementia…
  • 2018 International Congress

    Brain Perfusion pattern linked to depressive state in Parkinson’s: An arterial spin labelling MRI study

    Y. Xing, S. Naidu, S. Schwarz, N. Bajaj, D. Auer (Nottingham, United Kingdom)

    Objective: To investigate patterns of cerebral blood flow alteration associated with depressive state in Parkinson’s disease (PD) by using principal component analysis of arterial spin…
  • « Previous Page
  • 1
  • …
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley